Vicki Seyfert-Margolis, Ph.D. CEO, My Own Med Vicki Seyfert-Margolis, Ph.D. founded My Own Med in January 2013, based on over two years of work on a database, web and mobile application platform technology for family based co-management of health. Previously, Dr. Seyfert-Margolis was the Senior Advisor for Science Innovation and Policy in the Office of [...]
Bill Cassidy, M.D. United States Senator for Louisiana Dr. Bill Cassidy is the United States Senator for Louisiana. Bill grew up in Baton Rouge, Louisiana and attended Louisiana State University (LSU) for undergraduate and Medical School. For nearly three decades, Bill has provided care for uninsured and underinsured patients in Louisiana’s charity hospital system. During [...]
Jeff Brown, PhD Associate Professor Population Medicine, Harvard Medical School Dr. Brown is an Associate Professor and Director of Scientific Systems in the Department of Population Medicine (DPM) at Harvard Medical School and the Harvard Pilgrim Health Care Institute. He is Research Director of the Therapeutics Research and Infectious Disease program at DPM and Associate [...]
June 17th, 2015 – by Duane Schulthess
While progress is often slow and laborious when trying to gain traction for new ideas in the ‘Brussels Bubble’, there was much to be optimistic about in the Medicine’s Adaptive Pathways to Patients (MAPPs) meeting held on Thursday June 4 in Luxembourg. Organised as part of EFPIA’s general assembly, a broad cross section of stakeholders attended the MAPPs session to hear what had been accomplished over the last twelve months and discover how the initiative is being moved forward in partnership with the second Innovative Medicines Initiative (IMI2) and the European Medicine’s Agency (EMA).
May 29th, 2015 - by Vital TransformationHealthcare consultancy Vital Transformation is expanding to the United States with the addition of a new partner to head its operations in Washington D.C. Joseph P. Hammang, Ph.D., will join the Vital Transformation team, overseeing the company’s work in the U.S. and supporting its growing presence in Europe.
Better Science, Better Health New Trial Pathways and Better Patient Data Royal College of Physicians London October 21st, 2014 This event is by invitation only REQUEST INVITATION Conference overview: A gathering of the world’s thought leaders in medicine’s adaptive pathways to [...]
May 20th, 2015 – by Nuala MoranReal world evidence holds the potential to both increase efficiency in R&D and to bridge the gap between the proof of efficacy required to pass regulatory scrutiny and the demonstration of likely effectiveness needed to satisfy health technology assessment bodies, says Professor Sarah Garner, Associate Director for Science Policy and Research at NICE.
Kenneth Oye Professor of Political Science and Engeneering Systems, MIT Kenneth Oye holds a joint appointment in Political Science and Engineering Systems, with research and teaching on international relations, political economy and technology policy. His books include Cooperation under Anarchy, Economic Discrimination and Political Exchange, and the “Eagle” monographs on American foreign policy. His recent [...]
Irene Norstedt Acting Executive Director, IMI The IMI Governing Board appointed Irene Norstedt as Acting Executive Director of IMI as of 16 December 2014. Irene Norstedt comes from the European Commission, where she was Head of the Innovative and Personalised Medicine Unit at the European Commission’s Directorate-General for Research and Innovation. She has been at [...]
Barbara Lopez Kunz Global Chief Executive, DIA Barbara Lopez Kunz is leading the transformation of DIA through developing and implementing a strategy that focuses on driving innovation to improve the health of people worldwide. She is responsible for the leadership and oversight of DIA global operations and is accountable to the DIA Board of Directors. [...]